BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 16815652)

  • 1. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
    Bando H; McGinity JW
    Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.
    Bando H; McGinity JW
    Int J Pharm; 2006 Apr; 313(1-2):43-8. PubMed ID: 16487672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The manufacture and characterisation of hot-melt extruded enteric tablets.
    Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
    Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
    Schilling SU; Lirola HL; Shah NH; Waseem Malick A; McGinity JW
    J Microencapsul; 2010; 27(6):521-32. PubMed ID: 20575612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
    Kadam VD; Gattani SG
    Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
    Williams RO; Liu J
    Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of an enteric polymer on drug release rates of theophylline from pellets coated with Eudragit RS 30D.
    Wu C; McGinity JW
    Pharm Dev Technol; 2003; 8(1):103-10. PubMed ID: 12665203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of film additives on stabilizing drug release rates from pellets coated with acrylic polymers.
    Maejima T; McGinity JW
    Pharm Dev Technol; 2001; 6(2):211-21. PubMed ID: 11416995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.